Ultragenyx: building and leading the Innovation Lab
Built a global clinical technology organization connecting product, engineering, quality, informatics, and service operations around rare-disease research.
2019–2024
Discipline · 7 records
Clinical development and regulated systems
Sponsor-side leadership across clinical platforms, eCOA/ePRO, rare-disease monitoring, quality, and participant/site operations.
Rarify: a clinical platform from concept through study operations
Designed and deployed a GCP-aligned platform for collaborative patient/site data capture, decentralized research, and longitudinal disease monitoring.
2019–2024
eCOA and ePRO: requirements, sourcing, build decisions, and delivery
Led and developed a team responsible for selecting, building, validating, and supporting patient-reported clinical data capabilities.
Ultragenyx · 2019–2024
BEYONDXLH: longitudinal research and patient/site collaboration
Supported an Ultragenyx-sponsored disease monitoring program with Yale and the XLH Network, connecting longitudinal research to participant experience.
2019–2023
Rare-disease monitoring across metabolic and bone-disease programs
Brought patient-reported, clinical, device, and operational data together across natural-history, interventional, and long-term monitoring work.
Ultragenyx · 2019–2024
Quality, validation, and audit readiness in digital clinical development
Embedded quality and validation into development, release, change management, and continuing service operations.
Ultragenyx · 2019–2024
Pre-FPI review: signal feasibility and operational readiness
A structured method for examining endpoint workflows, sources, devices, site burden, handoffs, and governance before first patient in.
Trial Telemetry framework · 2026